Norges Bank Celldex Therapeutics, Inc. Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$30.29 - $38.28 $2.81 Million - $3.56 Million	-92,900 Closed	0 $0
Q2 2022 Aug 14, 2023	BUY	$20.5 - $37.33 $1.9 Million - $3.47 Million	92,900 New	92,900 $2.5 Million
Q3 2021 Nov 05, 2021	SELL	$28.95 - $55.99 $932,190 - $1.8 Million	-32,200 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$20.71 - $35.37 $666,862 - $1.14 Million	32,200 New	32,200 $1.08 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.26B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.